Merck Names China Expert as Directory of Strategy
September 28, 2011 at 12:10 PM EDT
Merck, known as MSD outside the United States and Canada, selected a member of WuXi PharmaTech’s board of directors to be its own Chief Strategy Director. Cuong Viet Do has experience in both healthcare and M&A, in addition to familiarity with China business. From 1989 to 2006, Do was a director and senior partner at McKinsey & Company, where he worked in global healthcare and then high-tech/corporate finance in China and Asia. Because of his extensive experience in Asia, Do’s appointment underscores the significance of China and Asia to Merck. More details.... Stock Symbols: (NYSE: MRK) (NYSE: WX) Share this with colleagues: var switchTo5x=true; stLight.options({publisher:'d7871f5b-67bc-4d30-b66f-1465d0b97213'});